Stock Analiz

Xenon Pharmaceuticals Inc. (XENE) stock forecast and price target

Price $40.48 · data as of November 13, 2026

12-month price target

Average target$71.69
Upside / downside+77.1%
Analysts16
ConsensusStrong buy
Low $46.00Average $71.69High $90.00

Gold marker: average target · white marker: today’s price ($40.48)

Analyst ratings

Strong buy 3Buy 14Hold 1Sell 0Strong sell 0

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends December 31, 2026
$-4.53−4.0%$416670
Next fiscal year
ends December 31, 2027
$-4.64−2.4%$24M
Next quarter
ends December 31, 2026
$-1.14+12.6%$416670
Quarter after
ends December 31, 2026
$-1.20+8.4%$0

Consensus of the analysts covering Xenon Pharmaceuticals, updated daily. In the last 30 days 1 estimates were raised and 0 lowered.

Frequently asked questions

What is the Xenon Pharmaceuticals stock price target?

The average 12-month target from 16 analysts is $71.69, 77.1% above the current price of $40.48 Targets range from $46.00 to $90.00.

Is Xenon Pharmaceuticals a buy according to analysts?

The consensus rating is “Strong buy” (3 strong buy, 14 buy, 1 hold). Ratings are opinions, not guarantees; this is not investment advice.

How much is Xenon Pharmaceuticals expected to earn?

Analysts expect EPS of $-4.53 for the fiscal year ending December 31, 2026 and $-4.64 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.